Eisai
4523.T
#1995
Rank
โ‚ฌ6.93 B
Marketcap
24,57ย โ‚ฌ
Share price
1.79%
Change (1 day)
-32.05%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): 2,05ย โ‚ฌ

According to Eisai's latest financial reports the company's current EPS (TTM) is 1,97ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 1,45ย โ‚ฌ a decrease over its 2021 EPS that were of 6,42ย โ‚ฌ.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)2,05ย โ‚ฌ41.92%
20221,45ย โ‚ฌ-77.48%
20216,42ย โ‚ฌ-41.88%
202011,04ย โ‚ฌ-0.94%
201911,15ย โ‚ฌ52.59%
20187,31ย โ‚ฌ124.17%
20173,26ย โ‚ฌ-49.42%
20166,44ย โ‚ฌ37.08%
20154,70ย โ‚ฌ-11.75%
20145,33ย โ‚ฌ-3.23%
20135,50ย โ‚ฌ-18.56%
20126,76ย โ‚ฌ-15.51%
20118,00ย โ‚ฌ-3.75%
20108,31ย โ‚ฌ-1.36%
20098,43ย โ‚ฌ